Eberechukwu Onukwugha
School of Pharmacy, Pharmaceutical Health Services Research

Eberechukwu Onukwugha

School of Pharmacy

28 Publications

This is a list of publications by this researcher, listed chronologically starting with the most recent first. New publications appear in this list weekly. The source of publications for this application is PubMed, so only PubMed publications are included.

Select All |

Export to Endnote

1.
2013

Eberechukwu Onukwugha

Improving Confidence in Observational Studies : Should Statistical Analysis Plans be Made Publicly Available?
PharmacoEconomics 2013;31(3):177-9.
2.
2012

C Daniel Mullins; Fei-Yuan Hsiao; Eberechukwu Onukwugha; Naimish B Pandya; Nader Hanna

Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients.
Cancer 2012;118(12):3173-81.
3.
2012

Emily S Reese; C Daniel Mullins; Amber L Beitelshees; Eberechukwu Onukwugha

Cost-effectiveness of cytochrome P450 2C19 genotype screening for selection of antiplatelet therapy with clopidogrel or prasugrel.
Pharmacotherapy 2012;32(4):323-32.
4.
2012

Eberechukwu Onukwugha; Elijah Saunders; C Daniel Mullins; Françoise G Pradel; Marni Zuckerman; F Ellen Loh; Matthew R Weir

A qualitative study to identify reasons for discharges against medical advice in the cardiovascular setting.
BMJ open 2012;2(4):.
5.
2012

J Samantha Shoemaker; Amy J Davidoff; Bruce Stuart; Ilene H Zuckerman; Eberechukwu Onukwugha; Christopher Powers

Eligibility and take-up of the Medicare Part D low-income subsidy.
Inquiry : a journal of medical care organization, provision and financing 2012;49(3):214-30.
6.
2012

Gail B Rattinger; C Daniel Mullins; Ilene H Zuckerman; Eberechukwu Onukwugha; Loreen D Walker; Adi Gundlapalli; Matthew Samore; Sylvain Delisle

A sustainable strategy to prevent misuse of antibiotics for acute respiratory infections.
PloS one 2012;7(12):e51147.
7.
2012

N N Hanna; E Onukwugha; M A Choti; A J Davidoff; I H Zuckerman; V D Hsu; C D Mullins

Comparative analysis of various prognostic nodal factors, adjuvant chemotherapy and survival among stage III colon cancer patients over 65 years: an analysis using surveillance, epidemiology and end results (SEER)-Medicare data.
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 2012;14(1):48-55.
8.
2011

Fei-Yuan Hsiao; C Daniel Mullins; Ebere Onukwugha; Naimish Pandya; Nader Hanna

Comparative effectiveness of different chemotherapeutic regimens on survival of people aged 66 and older with stage III colon cancer: a "real world" analysis using Surveillance, Epidemiology, and End Results-Medicare data.
Journal of the American Geriatrics Society 2011;59(9):1717-23.
9.
2011

Michael Grabner; Eberechukwu Onukwugha; Rahul Jain; C Daniel Mullins

Racial variation in the cost-effectiveness of chemotherapy for prostate cancer.
Journal of oncology practice / American Society of Clinical Oncology 2011;7(3 Suppl):e16s-24s.
10.
2011

Michael Grabner; Eberechukwu Onukwugha; Rahul Jain; C Daniel Mullins

Racial variation in the cost-effectiveness of chemotherapy for prostate cancer.
The American journal of managed care 2011;17(5 Spec No):e151-9.
11.
2011

Eberechukwu Onukwugha; C Daniel Mullins; Van Doren Hsu; Brian Seal; Arif Hussain

Effect of urologists and medical oncologists on treatment of elderly men with Stage IV prostate cancer.
Urology 2011;77(5):1088-95.
12.
2011

Myra Schneider; Ilene H Zuckerman; Eberechukwu Onukwugha; Naimish Pandya; Brian Seal; Jim Gardner; C Daniel Mullins

Chemotherapy treatment and survival in older women with estrogen receptor-negative metastatic breast cancer: a population-based analysis.
Journal of the American Geriatrics Society 2011;59(4):637-46.
13.
2011

Rahul Jain; Michael Grabner; Eberechukwu Onukwugha

Sensitivity analysis in cost-effectiveness studies: from guidelines to practice.
PharmacoEconomics 2011;29(4):297-314.
14.
2011

Eberechukwu Onukwugha; C Daniel Mullins; F Ellen Loh; Elijah Saunders; Fadia T Shaya; Matthew R Weir

Readmissions after unauthorized discharges in the cardiovascular setting.
Medical care 2011;49(2):215-24.
15.
2010

C Daniel Mullins; Eberechukwu Onukwugha; Jesse L Cooke; Arif Hussain; Claudia R Baquet

The potential impact of comparative effectiveness research on the health of minority populations.
Health affairs (Project Hope) 2010;29(11):2098-104.
16.
2010

G B Rattinger; C D Mullins; I H Zuckerman; E Onukwugha; S Delisle

Clinic visits and prescribing patterns among Veterans Affairs Maryland Health Care System dementia patients.
The journal of nutrition, health & aging 2010;14(8):677-83.
17.
2010

Eberechukwu Onukwugha; Elijah Saunders; C Daniel Mullins; Françoise G Pradel; Marni Zuckerman; Matthew R Weir

Reasons for discharges against medical advice: a qualitative study.
Quality & safety in health care 2010;19(5):420-4.
18.
2010

C Daniel Mullins; Eberechukwu Onukwugha; Kaloyan Bikov; Brian Seal; Arif Hussain

Health disparities in staging of SEER-medicare prostate cancer patients in the United States.
Urology 2010;76(3):566-72.
19.
2010

Jay M Margolis; Zhun Cao; Eberechukwu Onukwugha; Robert J Sanchez; Jose Alvir; Ashish V Joshi; C Daniel Mullins

Healthcare utilization and cost effects of prior authorization for pregabalin in commercial health plans.
The American journal of managed care 2010;16(6):447-56.
20.
2010

John F P Bridges; Eberechukwu Onukwugha; C Daniel Mullins

Healthcare rationing by proxy: cost-effectiveness analysis and the misuse of the $50,000 threshold in the US.
PharmacoEconomics 2010;28(3):175-84.
21.
2009

Amy J Davidoff; Thomas Rapp; Ebere Onukwugha; Ilene H Zuckerman; Nader Hanna; Naimish Pandya; C Daniel Mullins

Trends in disparities in receipt of adjuvant therapy for elderly stage III colon cancer patients: the role of the medical oncologist evaluation.
Medical care 2009;47(12):1229-36.
22.
2009

Jay M Margolis; Stephen S Johnston; Bong-Chul Chu; Eberechukwu Onukwugha; Kyle Hvidsten; Jose Alvir; Joseph G Rossi; C Daniel Mullins

Effects of a Medicaid prior authorization policy for pregabalin.
The American journal of managed care 2009;15(10):e95-102.
23.
2009

Ilene H Zuckerman; Thomas Rapp; Ebere Onukwugha; Amy Davidoff; Michael A Choti; James Gardner; Brian Seal; C Daniel Mullins

Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.
Journal of the American Geriatrics Society 2009;57(8):1403-10.
24.
2009

Ebere Onukwugha; Ilene H Zuckerman; Diane McNally; Karin S Coyne; Vasudha Vats; C Daniel Mullins

The total economic burden of overactive bladder in the United States: a disease-specific approach.
The American journal of managed care 2009;15(4 Suppl):S90-7.
25.
2009

Ebere Chukwu Onukwugha; Fadia T Shaya; Elijah Saunders; Matthew R Weir

Ethnic disparities, hospital quality, and discharges against medical advice among patients with cardiovascular disease.
Ethnicity & disease 2009;19(2):172-8.
26.
2009

E Onukwugha; M R Weir

The dual impact of rehabilitation admission and race/ethnicity on discharges against medical advice.
NeuroRehabilitation 2009;24(1):67-74.
27.
2008

Ebere Onukwugha; C Daniel Mullins; Sylvain DeLisle

Using cost-effectiveness analysis to sharpen formulary decision-making: the example of tiotropium at the Veterans Affairs health care system.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2008;11(5):980-8.
28.
2007

Ebere Onukwugha; C Daniel Mullins

Racial differences in hospital discharge disposition among stroke patients in Maryland.
Medical decision making : an international journal of the Society for Medical Decision Making 2007;27(3):233-42.

Eberechukwu Onukwugha School of Pharmacy, Pharmaceutical Health Services Research

Eberechukwu Onukwugha

28 Publications

Eberechukwu Onukwugha
School of Pharmacy, Pharmaceutical Health Services Research